Oct 19th 2009
Nuformix, with locations in Wilton and Cambridge has secured GRD funding of ca. £250k (under the UK Government Grant for Research and Development Scheme) through One North East. GRD funding will enable Nuformix to accelerate and extend it’s R&D programme and maintain a competitive global position.
In addition, this additional funding will enable Nuformix to take its products further up the value chain, creating greater value by de-risking products for customers. Overall, GRD funding will enable a more rapid development plan that will deliver higher-value products than would have otherwise been possible.
Oct 2nd 2008
Nuformix, a virtual drug development start-up with locations in Wilton and Cambridge closed its Round A funding call, securing significant private investment to execute a comprehensive product development and out-licensing strategy. Funding was secured ahead of the Management Team’s expectations as a result of a compelling business model.
Initial activities will focus on solid form optimisation studies across a range of current drugs identified as having sub-optimal performance as a result of poor solid form selection. It is expected that the funds raised will be sufficient to complete an extensive R&D programme in addition to product validation and out-licensing activities.
This first phase of Nuformix’s existence will validate the value of solid form in shortening product development cycles, reducing risk in product development and the creation of new opportunities in life cycle management and drug reprofiling.
